The V118I mutation is included in the nucleoside analogue mutations (NAMs) set. It contributes to thymidine-analogue resistance and, consequently, to resistance to the whole nucleoside reverse transcriptase inhibitor (NRTI) class. We focused on the V1181 mutation in order to evaluate factors associated with its detection and its relationship with HIV progression.
Zaccarelli, M., Tozzi, V., Lorenzini, P., Forbici, F., Narciso, P., CECCHERINI SILBERSTEIN, F., et al. (2007). The V118I mutation as a marker of advanced HIV infection and disease progression. ANTIVIRAL THERAPY, 12(2), 163-168.
The V118I mutation as a marker of advanced HIV infection and disease progression
CECCHERINI SILBERSTEIN, FRANCESCA;BERTOLI, ADA;PERNO, CARLO FEDERICO;
2007-01-01
Abstract
The V118I mutation is included in the nucleoside analogue mutations (NAMs) set. It contributes to thymidine-analogue resistance and, consequently, to resistance to the whole nucleoside reverse transcriptase inhibitor (NRTI) class. We focused on the V1181 mutation in order to evaluate factors associated with its detection and its relationship with HIV progression.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
